Karsten Bjerre

1.1k total citations
30 papers, 832 citations indexed

About

Karsten Bjerre is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Karsten Bjerre has authored 30 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Karsten Bjerre's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Treatment and Pharmacology (7 papers). Karsten Bjerre is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Treatment and Pharmacology (7 papers). Karsten Bjerre collaborates with scholars based in Denmark, United States and Sweden. Karsten Bjerre's co-authors include Susanne Möller, Peer Christiansen, Bent Ejlertsen, Henning T. Mouridsen, Maj‐Britt Jensen, Martin J. Larsen, Michael Andersson, Jonas Bergh, Peter G. Sørensen and Per Karlsson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Karsten Bjerre

28 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karsten Bjerre Denmark	13	551	381	145	121	101	30	832
Toufic Eid Lebanon	11	279 0.5×	131 0.3×	87 0.6×	56 0.5×	44 0.4×	20	520
Moo Hyun Lee South Korea	13	160 0.3×	162 0.4×	93 0.6×	75 0.6×	96 1.0×	27	552
Wolfgang Gatzemeier Italy	17	300 0.5×	454 1.2×	98 0.7×	270 2.2×	128 1.3×	59	834
César Sánchez Chile	14	425 0.8×	208 0.5×	180 1.2×	76 0.6×	53 0.5×	81	779
René Aloísio da Costa Vieira Brazil	15	392 0.7×	246 0.6×	68 0.5×	72 0.6×	148 1.5×	63	721
Nicola Roche United Kingdom	8	315 0.6×	285 0.7×	68 0.5×	100 0.8×	103 1.0×	18	629
Jihyoung Cho South Korea	14	225 0.4×	353 0.9×	82 0.6×	274 2.3×	211 2.1×	52	752
Emily Bellavance United States	15	186 0.3×	159 0.4×	55 0.4×	47 0.4×	156 1.5×	36	651
Shelly S. Lo United States	10	286 0.5×	267 0.7×	105 0.7×	66 0.5×	64 0.6×	37	591
Umut Demırcı Türkiye	17	416 0.8×	111 0.3×	357 2.5×	103 0.9×	148 1.5×	113	950

Countries citing papers authored by Karsten Bjerre

Since Specialization

Citations

This map shows the geographic impact of Karsten Bjerre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Bjerre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Bjerre more than expected).

Fields of papers citing papers by Karsten Bjerre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Bjerre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Bjerre. The network helps show where Karsten Bjerre may publish in the future.

Co-authorship network of co-authors of Karsten Bjerre

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Bjerre. A scholar is included among the top collaborators of Karsten Bjerre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Bjerre. Karsten Bjerre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hounmanou, Yaovi Mahuton Gildas, Jørgen Engberg, Karsten Bjerre, et al.. (2023). Correlation of High Seawater Temperature with Vibrio and Shewanella Infections, Denmark, 2010–2018. Emerging infectious diseases. 29(3). 605–608. 11 indexed citations

Hedley, Paula L., Steen Hoffmann, Ulrik Lausten‐Thomsen, et al.. (2022). A Nationwide Observational Study of Chlamydia trachomatis Infections in Denmark during the COVID-19 Pandemic. Acta Dermato Venereologica. 102. adv00704–adv00704. 4 indexed citations

Amato, Ettore, Maximilian Rieß, Daniel Thomas‐López, et al.. (2022). Epidemiological and microbiological investigation of a large increase in vibriosis, northern Europe, 2018. Eurosurveillance. 27(28). 35 indexed citations

Bjerre, Karsten, Lasse Dam Rasmussen, Erik Jensen, et al.. (2020). Detection of norovirus infections in Denmark, 2011–2018. Epidemiology and Infection. 148. e52–e52. 4 indexed citations

Bech, Bodil Hammer, Oleguer Plana‐Ripoll, Hanne Vestergaard, et al.. (2020). Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? – A Danish nationwide matched case-control study. Vaccine. 38(35). 5678–5684.

Bodilsen, Anne, Karsten Bjerre, B.V. Offersen, et al.. (2016). Abstract S2-01: Importance of margin width and re-excision in breast conserving treatment of early breast cancer; a Danish breast cancer cooperative group study of 11,900 women. Cancer Research. 76(4_Supplement). S2–1. 2 indexed citations

Bodilsen, Anne, Karsten Bjerre, Birgitte Vrou Offersen, et al.. (2015). The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study. Annals of Surgical Oncology. 22(S3). 476–485. 32 indexed citations

Ejlertsen, Bent, et al.. (2014). TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group. BMC Cancer. 14(1). 360–360. 4 indexed citations

Larsen, Mathilde Skaarup, Karsten Bjerre, Anita Giobbie‐Hurder, et al.. (2012). Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy. Acta Oncologica. 51(6). 781–789. 18 indexed citations

10.

Larsen, Mathilde Skaarup, Karsten Bjerre, Anne E. Lykkesfeldt, et al.. (2012). Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy. The Breast. 21(5). 662–668. 7 indexed citations

11.

Teilum, Dorthe, Karsten Bjerre, Anne Tjønneland, & Niels Kroman. (2012). Breast cancer survival and season of surgery: an ecological open cohort study. BMJ Open. 2(1). e000358–e000358. 2 indexed citations

12.

Knoop, Ann, Karsten Bjerre, Mathilde Skaarup Larsen, et al.. (2012). Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. Acta Oncologica. 52(1). 82–90. 11 indexed citations

13.

Christiansen, Peer, Karsten Bjerre, Bent Ejlertsen, et al.. (2011). Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark. JNCI Journal of the National Cancer Institute. 103(18). 1363–1372. 38 indexed citations

14.

Edlund, Per, Johan Ahlgren, Karsten Bjerre, et al.. (2011). Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1. Acta Oncologica. 50(3). 329–337. 10 indexed citations

15.

Nielsen, Dorte, Karsten Bjerre, Erik Jakobsen, et al.. (2011). Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group. Journal of Clinical Oncology. 29(36). 4748–4754. 25 indexed citations

16.

Rosendahl, Mikkel, Johan Ahlgren, Jørn Andersen, et al.. (2009). The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study. European Journal of Cancer. 45(18). 3198–3204. 16 indexed citations

17.

Möller, Susanne, Maj‐Britt Jensen, Bent Ejlertsen, et al.. (2008). The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncologica. 47(4). 506–524. 231 indexed citations

18.

Mouridsen, Henning T., Karsten Bjerre, Peer Christiansen, Maj‐Britt Jensen, & Susanne Möller. (2008). Improvement of prognosis in breast cancer in Denmark 1977–2006, based on the nationwide reporting to the DBCG Registry. Acta Oncologica. 47(4). 525–536. 36 indexed citations

19.

Christiansen, Peer, et al.. (2008). Recurrence pattern and prognosis in low-risk breast cancer patients – Data from the DBCG 89-A programme. Acta Oncologica. 47(4). 691–703. 46 indexed citations

20.

Kiær, Henrik, et al.. (2008). Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978–2006. Acta Oncologica. 47(4). 778–783. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact